FDA approves first superbug rapid blood detector

the U.SFood and Drug Administration
approved a blood tester for "superbug" MRSA for clinical useFebruaryThis is the firstin the United States to be approved for clinical MRSA rapid detectioninstrumentsMRSA, an acronym for Methicillin-resistant Staphylococcus aureus, is resistant to the antibiotic methicillin and is therefore known as a "superbug"MRSA is more threatening than regular staphylococcus, can kill in severe cases, and conventional antibiotic treatment does not workTherefore, the rapid,accurate detection of patient infection is not MRSA,is critical for diagnosis and treatmentThe newly approved blood test, called "BD GeneOhm",, wasdeveloped by BD Corporation of New Jersey, USA The U.S Drug Administration issued a statement on the of the 2nd
the instrument the use of molecular testing methods , can be based on the difference between genetic material and quickly identify the patient infected with MRSA or ordinary staphylococcus , within two hours to obtain results It usually takes more than two days to detect MRSA using previous methods to produce results Clinical trial results show that the new blood detector detected MRSA with 100% accuracy, and the accuracy of detecting common staphylococcus bacteria is more than 98%